Gastroenterology
Volume 136, Issue 1 , Pages 149-159.e2 , January 2009

A Randomized Controlled Trial of Antioxidant Supplementation for Pain Relief in Patients With Chronic Pancreatitis

  • Payal Bhardwaj

      Affiliations

    • Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India
  • ,
  • Pramod Kumar Garg

      Affiliations

    • Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India
    • Corresponding Author InformationAddress requests for reprints to: Pramod Kumar Garg, MD, Associate Professor, Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi 110029, India. fax: 91-11-26588663
  • ,
  • Subir Kumar Maulik

      Affiliations

    • Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India
  • ,
  • Anoop Saraya

      Affiliations

    • Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India
  • ,
  • Rakesh Kumar Tandon

      Affiliations

    • Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India
  • ,
  • Subrat Kumar Acharya

      Affiliations

    • Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India

Received 2 June 2008 ,Accepted 18 September 2008.

References 

  1. Witt H, Apte MV, Keim V, et al. Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy. Gastroenterology. 2007;132:1557–1573
  2. Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology. 2001;120:682–707
  3. Tandon RK, Sato N, Garg PK. Chronic pancreatitis: Asia-Pacific consensus report. J Gastroenterol Hepatol. 2002;17:508–518
  4. Di Sebastiano P, di Mola FF, Buchler MW, et al. Pathogenesis of pain in chronic pancreatitis. Dig Dis. 2004;22:267–272
  5. AGA Technical Review. Treatment of pain in chronic pancreatitis. Gastroenterology. 1998;115:765–776
  6. Rösch T, Daniel S, Scholz M, et al. European Society of Gastrointestinal Endoscopy Research Group Endoscopic treatment of chronic pancreatitis: a multicenter study of 1000 patients with long-term follow-up. Endoscopy. 2002;34:765–771
  7. Cahen DL, Gouma DJ, Nio Y, et al. Endoscopic versus surgical drainage of the pancreatic duct in chronic pancreatitis. N Engl J Med. 2007;356:676–684
  8. Uden S, Acheson DW, Reeves J, et al. Antioxidants, enzyme induction, and chronic pancreatitis: A reappraisal following studies in patients on anticonvulsants. Eur J Clin Nutr. 1988;42:561
  9. Schoenberg MH, Buchler M, Pietrzyk C, et al. Lipid peroxidation and glutathione metabolism in chronic pancreatitis. Pancreas. 1995;10:36–43
  10. Van Gossum A, Closset P, Noel E, et al. Deficiency in antioxidant factors in patients with alcohol-related chronic pancreatitis. Dig Dis Sci. 1996;4:1225–1231
  11. Liska DJ. The detoxification enzyme systems. Altern Med Rev. 1998;3:187–198
  12. Lu Y, Cederbaum AI. CYP2E1 and oxidative liver injury by alcohol. Free Radic Biol Med. 2008;44:723–738
  13. Park BK, Kitteringham NR, Pirmohamed M, Tucker GT. Relevance of induction of human drug-metabolizing enzymes: pharmacological and toxicological implications. Br J Clin Pharmacol. 1996;41:477–491
  14. Telek G, Regöly-Mérei J, Kovács GC, et al. The first histological demonstration of pancreatic oxidative stress in human acute pancreatitis. Hepatogastroenterology. 2001;48:1252–1258
  15. Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44–84
  16. Droge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002;82:47–95
  17. McCloy R. Chronic pancreatitis at Manchester, UK (Focus on antioxidant therapy). Digestion. 1998;59(Suppl 4):36–48
  18. Szuster-Ciesielska A, Daniluk J, Kandefer-Szerszen M. Oxidative stress in blood of patients with alcohol-related pancreatitis. Pancreas. 2001;22:261–266
  19. Verlaan M, Roelofs HM, van-Schaik A, et al. Assessment of oxidative stress in chronic pancreatitis patients. World J Gastroenterol. 2006;12:5705–5710
  20. Braganza JM, Schofield D, Snehalatha C, et al. Micronutrient antioxidant status in tropical compared with temperate-zone chronic pancreatitis. Scand J Gastroenterol. 1993;28:1098–1104
  21. Uden S, Schofield D, Miller PF, et al. Antioxidant therapy for recurrent pancreatitis: biochemical prefiles in a placebo-controlled trial. Aliment Pharmacol Ther. 1992;6:229–240
  22. Kirk GR, White JS, McKie L, et al. Combined antioxidant therapy reduces pain and improves quality of life in chronic pancreatitis. J Gastrointest Surg. 2006;10:499–503
  23. Garg PK, Tandon RK. Survey on chronic pancreatitis in the Asia-Pacific region. J Gastroenterol Hepatol. 2004;19:998–1004
  24. WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. The Lancet. 2004;363:157–163
  25. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications (Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation). Diabet Med. 1998;15:539–553
  26. Van De Kamer JH. Quantitative determination of the saturated and unsaturated higher fatty acids in fecal fat. Scand J Clin Lab Invest. 1953;5:30–36
  27. Madan K, Bhardwaj P, Thareja S, et al. Oxidant stress and antioxidant status among patients with non alcoholic fatty liver disease (NAFLD). J Clin Gastroenterol. 2006;40:930–935
  28. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;12:302–310
  29. Marklund S, Marklund G. Involvement of superoxde anion radical in the autooxidation of pyragallol and a convenient assay for SOD. Eur J Biochem. 1974;47:469–474
  30. Griffith OW. Determination of glutathione and glutathione disulphide using glutathione reductase and 2-vinylpyridine. Anal Biochem. 1980;106:207–212
  31. Benzie IFF, Strain JJ. The Ferric Reducing Ability of Plasma (FRAP) as a measure of “Antioxidant Power”: The FRAP Assay. Anal Biochem. 1996;239:70–76
  32. Nino HV, Shaw W. Vitamins. In:  Tietz NW editors. Fundamentals of Clinical Chemistry. Philadelphia: W.B. Saunders Co; 1976;p. 1278
  33. Sami AH, George RS. Rapid determination of tocopherol in macro and microquantities of plasma. Am J Clin Nutr. 1966;19:137–145
  34. Okamura M. An improved method for determination of L-ascorbic acid and L-dehydroascorbic acid in blood plasma. Clinica Chemica Acta. 1980;103:259–268
  35. Nandi B, Garg PK, Bhardwaj P, et al. Efficacy of antioxidants for pain relief in patients with chronic pancreatitis: A randomized controlled trial. Ind J Gastroenterol. 2002;21(Suppl 1):A43
  36. Brown A, Hughes M, Tenner S, et al. Does pancreatic enzyme supplementation reduce pain in patients with chronic pancreatitis: a meta-analysis. Am J Gastroenterol. 1997;92:2032–2035
  37. Shrikhande SV, Martignoni ME, Shrikhande M, et al. Comparison of histological features and inflammatory cell reaction in alcoholic, idiopathic and tropical chronic pancreatitis. Br J Surg. 2003;90:1565–1572
  38. Schneider A, Haas SL, Hildenbrand R, et al. Enhanced expression of interleukin-18 in serum and pancreas of patients with chronic pancreatitis. World J Gastroenterol. 2006;12:6507–6514
  39. Ceyhan GO, Michalski CW, Demir IE, et al. Pancreatic pain. Best Pract Res Clin Gastroenterol. 2008;22:31–44
  40. Ammann RW. The natural history of alcoholic chronic pancreatitis. Intern Med. 2001;40:368–375
  41. Ammann RW, Muellhaupt B. The natural history of pain in alcoholic chronic pancreatitis. Gastroenterology. 1999;116:1132–1140
  42. Bhatia E, Choudhuri G, Sikora SS, et al. Tropical calcific pancreatitis: strong association with SPINK1 trypsin inhibitor mutations. Gastroenterology. 2002;123:1020–1025
  43. Pfutzer RH, Barmada MM, Brunskil APJ J, et al. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology. 2000;119:615–623
  44. Midha S, Singh N, Sachdev V, et al. Cause and effect relationship of malnutrition with idiopathic chronic pancreatitis: prospective case-control study. J Gastroenterol Hepatol. 2008;23:1378–1383
  45. Balakrishnan V, Nair P, Radhakrishnan L, Narayanan VA. Tropical pancreatitis—a distinct entity, or merely a type of chronic pancreatitis?. Indian J Gastroenterol. 2006;25:74–81
  46. Jones S. Was there a Hawthorne effect?. Am J Sociol. 1992;98:451–468
  47. Whiteley G, Kienle A, Lee S, et al. Micronutrient antioxidant therapy in the nonsurgical management of painful chronic pancreatitis: long term observation. Pancreas. 1994;9:A807
  48. Banks PA, Hughes M, Ferrante M, et al. Does allopurinol reduce pain of chronic pancreatitis?. Int J Pancreatol. 1997;22:171–176
  49. Braganza JM. The pathogenesis of chronic pancreatitis. Q J Med. 1996;89:243–250
  50. Foster JR, Idle JR, Hardwick JP, et al. Induction of drug-metabolizing enzymes in human pancreatic cancer and chronic pancreatitis. J Pathol. 1993;169:457–463
  51. Morris-Stiff GJ, Bowrey DJ, Oleesky D, et al. The antioxidant profiles of patients with recurrent acute and chronic pancreatitis. Am J Gastroenterol. 1999;94:2135–2140
  52. Xu G, Winston JH, Shenoy M, et al. Transient receptor potential vanilloid 1 mediates hyperalgesia and is up-regulated in rats with chronic pancreatitis. Gastroenterology. 2007;133:1282–1292
  53. Bautista DM, Jordt SE, Nikai T, et al. TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell. 2006;124:1269–1282
  54. Trevisani M, Siemens S, Bautista DM, et al. 4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1. Proc Natl Acad Sci U S A. 2007;104:13519–13524
  55. Bjelakovic G, Nikolova D, Gluud LL, et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007;297:842–857
  56. Siriwardena AK, Mason JM, Balachandra S, et al. Randomised, double blind, placebo controlled trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in severe acute pancreatitis. Gut. 2007;56:1439–1444

 The authors disclose the following: Supported by Indian Council of Medical Research, New Delhi, India, through an individual fellowship grant to Payal Bhardwaj under the guidance of Dr Anoop Saraya. Osper Pharmanautics provided the drug and placebo on a complimentary basis. The supporting sources had no role in study design, collection of data, interpretation of data, writing of the manuscript, or submission for publication.

PII: S0016-5085(08)01697-1

doi: 10.1053/j.gastro.2008.09.028

Gastroenterology
Volume 136, Issue 1 , Pages 149-159.e2 , January 2009